A cell-targeted, payload-delivering DNA nanorobot developed at the Wyss Institute (2013) that can trigger targeted therapeutic responses. This novel technology could potentially seek out cancer cells and cause them to self-destruct
A cell-targeted, payload-delivering DNA nanorobot developed at the Wyss Institute (2013) that can trigger targeted therapeutic responses. This novel technology could potentially seek out cancer cells and cause them to self-destruct